We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Luminex Corporation | NASDAQ:LMNX | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 36.99 | 36.94 | 36.98 | 0 | 01:00:00 |
From Jul 2019 to Jul 2024
AUSTIN, Texas, July 17, 2017 /PRNewswire/ -- Luminex Corporation (NASDAQ: LMNX) today announced that it expects to report results for the second quarter ended June 30, 2017 on Monday, August 7, 2017. A press release announcing the results is scheduled for release after the close of trading on that date.
Management will hold a conference call to discuss the operating highlights and financial results for the second quarter ended June 30, 2017 on August 7, 2017, at 4:30 p.m. Eastern time.
The conference call will be webcast live and may be accessed at Luminex Corporation's website at http://www.luminexcorp.com. Simply log on to the website, go to the About Luminex section and access the Investor Relations link. Please go to the website at least 15 minutes prior to the call to register, download and install any necessary audio/video software. If you are unable to participate during the live webcast, the call will be archived for six months on the website using the 'replay' link.
About Luminex Corporation
At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health. We offer a wide range of solutions applicable in diverse markets including clinical diagnostics, pharmaceutical drug discovery, biomedical research, genomic and proteomic research, biodefense research, and food safety. We accelerate reliable answers while simplifying complexity and deliver certainty with a seamless experience. To learn more about Luminex, please visit us at www.luminexcorp.com.
Luminex Corporate Contact:
Harriss Currie, 512.219.8020
Sr. Vice President, Finance and CFO
hcurrie@luminexcorp.com
Luminex Investor Contact:
Matthew Scalo, 512.219.8020
Sr. Director, Investor Relations
mscalo@luminexcorp.com
View original content with multimedia:http://www.prnewswire.com/news-releases/luminex-corporation-second-quarter-earnings-release-scheduled-for-august-7-2017-300488585.html
SOURCE Luminex Corporation
Copyright 2017 PR Newswire
1 Year Luminex Chart |
1 Month Luminex Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
